Celldex Therapeutics stockCLDX
Celldex Therapeutics trades at $28.27, 37.4% below its 52-week high (Aug 12, 2026). The price is below its 50- and 200-day averages, a downtrend. +4.1% year to date, +19.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 11, 2026.
Ratings, candles, signals and the screener for CLDX — after you log in
Open the terminalFrequently asked questions about Celldex Therapeutics
What is the Celldex Therapeutics stock price?
At the close on Nov 5, 2026: $28.27 (−5.55% on the day). 52-week high: $45.14 on Aug 12, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Celldex Therapeutics report earnings?
The next quarterly report is on Nov 11, 2026. Last quarter, earnings per share changed −11% year over year, revenue −97%.
Does Celldex Therapeutics pay dividends?
No, Celldex Therapeutics does not pay dividends.
Where does Celldex Therapeutics trade and how to buy it?
Ticker CLDX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Celldex Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for CLDX are in the terminal after you log in.